Absorption |
Blood-Brain Barrier | BBB+ | 0.9744 |
Human Intestinal Absorption | HIA+ | 0.9930 |
Caco-2 Permeability | Caco2+ | 0.7746 |
P-glycoprotein Substrate | Substrate | 0.8179 |
P-glycoprotein Inhibitor | Inhibitor | 0.8117 |
Inhibitor | 0.5974 |
Renal Organic Cation Transporter | Inhibitor | 0.8458 |
Distribution |
Subcellular localization | Lysosome | 0.5191 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7426 |
CYP450 2D6 Substrate | Non-substrate | 0.9117 |
CYP450 3A4 Substrate | Substrate | 0.6451 |
CYP450 1A2 Inhibitor | Inhibitor | 0.7168 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7691 |
CYP450 2D6 Inhibitor | Inhibitor | 0.7938 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8336 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.6613 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5250 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9516 |
Non-inhibitor | 0.5121 |
AMES Toxicity | Non AMES toxic | 0.9132 |
Carcinogens | Non-carcinogens | 0.8739 |
Fish Toxicity | High FHMT | 0.9598 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9585 |
Honey Bee Toxicity | Low HBT | 0.8687 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.8018 |
Carcinogenicity (Three-class) | Non-required | 0.7371 |